John R. Franklin, M.D., M.A

Public Health School

• Columbia School of Public Health (Epidemiology)
  M.P.H., [Degree expected when final paper finished]
  
  
• UCLA School of Public Health, Department of Epidemiology, M.P.H., September 1996 - June 1997

Medical School

• Columbia University College of Physicians and
  Surgeons, M.D. Degree - May 1988
  
  
• College/Graduate Queens College, Queens, New York

School

• Premedical Program, Major in Chemistry
  B.A. Degree, Cum Laude - September 1980 to May 1984
  
  
• Queens College, Queens, New York
  Premedical Program, Major in Chemistry
  M.A. Degree - September 1980 to May 1984

• Staff Physician III - Urology
  The Roy L. Schneider Hospital
  February 2000 to Present
  
  
• Staff Physician - Urology
  Juan Luis Hospital
  2002 to 2010
  
  
• Director
  Virgin Islands Urologic Center, Inc.
  February 2000 to Present
  
  
• Assistant Professor of Urology
  Columbia University
  March 1998 – January 2000
  
  
• Assistant Attending
  New York Presbyterian Hospital
  March 1998 – January 2000
  
  
• Assistant Attending
  St. Lukes/Roosevelt Hospital
  January 1998 to January 2000
  
  
• Assistant Professor in Urology (Oncologist)
  Albert Einstein College of Medicine/Montefiore Medical Center
  July 1997 - January 1998
  
  
• Urologic Oncologist
  West Los Angeles, Veterans Affairs Medical Center (Wadsworth)
  July 8, 1996 - July 1997
  
  
• Co-Chairman, Prostate Cancer Center of Excellence
  West Los Angeles, Veterans Affairs Medical Center (Wadsworth)
  December 1996 - July 1997
  
  
• Assistant Clinical Professor
  UCLA School of Medicine, Department of Urology
  July 1, 1996 - June 1997
  
  
• Research Urologic Oncology Fellow/Clinical Instructor
  UCLA School of Medicine, Division of Urology, Department of Surgery
  July 1995 - June 1996
  
  
• Clinical Urologic Oncology Fellow/Clinical Instructor
  UCLA School of Medicine, Division of Urology, Department of Surgery
  July 1994 - June 1995
  
  
• Urology Residency
  Columbia University, Urology Department
  July 1990 - June 1994
  
  
• Research
  Columbia University, Urology Research Department
  July 1989 - June 1990
  
  
• Internship
  Nassau County Medical Center
  Categorical General Surgical Residency
  July 1, 1988 - June 30, 1989

• 1998 American Board of Urology (Diplomate)

• Virgin Islands Medical License
  January 3, 2000 (active)
  
  
• DEA Number BF3929190
  Expiration
  September, 2020

• American Urologic Association (National)
• AUA (New York Section)
• National Medical Association

• Peer Reviewer, The Journal of Urology
• Peer Reviewer, Urology

• UCLA’s Department of Epidemiology, School of Public Health Traineeship Award - 1996
• National Institute of Health, Tumor Immunology Training Grant - June 1995
• American Foundation for Urologic Disease, Inc., National Kidney Foundation Joint Resident Fellowships - 1992
• First Prize Essay Contest Winner - The Society of Basic Urologic Research - 1992
• Salk Scholar Award - 1984
• Queens College Graduate Student Award - 1984
• Queens College Division of Mathematics and the Natural Sciences Award - Honors in Chemistry - 1984

• Principal Investigator: A National Phase II Trial of Intron, Interferon alfa Treatment of Superficial Bladder Cancer. Schering. Dates 11/1999 to 1/31/2000
  
  
• Principal Investigator: Race/Ethnic based genetic variations in human genes: Defining the genetic evidence for disparity of prostate cancer risk and mortality between different populations. Department of Defense, Prostate Cancer Research Program, Minority Population Focused Training Award. Dates 2/15/99 to 8/14/99
  
  
• Principal Investigator: A phase II open randomized multi-center trial to determine the efficacy and safety of the combination of liarozole with prednisone in patients with relapse hormone-resistant prostate cancer. LIA-INT-29. Janssen Research Foundation
  
  
• Principal Investigator: International phase II randomized double blind, multi-center study of liarozole in patients with rising PSA after definitive therapy. LIA-INT-26. Janssen Research Foundation
  
  
• Co-Investigator: Ethnicity and Veteran Identity as Determinants of VA Ambulatory Care Use (Pending minor revisions)

1. Belldegrun AS, Franklin JR, O’Donnell MA, Gomella LG, Klein E, Neir R, Nseyo UO, Ratliff TL, and Richards W: Superficial Bladder Cancer: The role of Interferon alpha therapy. J Urol, 159:1793-1799, (1998)
   
   
2. Figlin R, Gitlitz B, Franklin J, Dorey F, Moldawer N, Rausch J, deKernion J, and Belldegrun A: Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients. Cancer J Scientific Amer., 3(suppl 1): 92-97, (1997)
   
   
3. Hoh C, Spencer MA, Franklin J, deKernion JB, Phelps ME, Belldegrun A: Positron emission tomography in urologic oncology. J Urol, 159: 347-356, (1997)
   
   
4. Patel A, Dorey F, Franklin J, and deKernion J: Recurrence patterns after radical retropubic prostatectomy: Clinical utility of PSA doubling times and log slope PSA (prostate specific antigen). J Urol., 158: 1441-1445, (1997)
   
   
5. Franklin JR, and Belldegrun AS: Tumor immunity. In Oesterling J, and Richie J (eds), Urologic Oncology. Philadelphia PA, Saunders, pp 34-52, (1997)
   
   
6. Franklin JR, Figlin R, Rauch J, Gitlitz B, Dorey F, deKernion JB, and Belldegrun AS: The role of cytoreductive surgery in the management of metastatic renal cell carcinoma. Seminars in Urologic Oncology 14 (4):230 (1996)
   
   
7. Franklin JR, Figlin R, Belldegrun AS: Renal cell carcinoma: Basic biology and clinical behavior. Seminars in Urologic Oncology 14 (4):208 (1996)
   
   
8. Franklin JR, Raz S, deKernion JB: Female neobladder construction utilizing the UCLA 1 (ileocolic) pouch. In Olsson CA (ed), Surgical Techniques in Urology. 8 (5) (1995)
   
   
9. Franklin JR, deKernion JB: Kidney tumors - what’s new? Current Opinions in Urology 5 (5):225 (1995)
   
   
10. Belldegrun A, Franklin JR, Figlin R: Prognostic factors in renal cell carcinoma. J Urol. 154:1274 (1995)
    
    
11. deKernion JB, Franklin JR, Belldegrun A, and Smith RB. Surgery for Clinically Localized Prostate Cancer. In RTD Oliver et al. (ed), Preventing Prostate Cancer: Screening versus Chemoprevention. Cold Spring Harbor Laboratory Press New York, pp 315-320 (1995)
    
    
12. Franklin JR, and deKernion JB. Surgical Approaches To Renal Cell Carcinoma. in MS Ernstoff et al. (ed), Urologic Cancer. W.W. Norton & Company, N.Y., London (1996)
    
    
13. Franklin J, and Benson M. New Techniques in Management and Treatment of Superficial Bladder Cancer. In DE Neal (ed.), Tumours in Urology. Springer-Verlag London Berlin Heidelberg New York, pp 65-78 (1994)
    
    
14. Franklin JR, Olsson CA, and Sawczuk IS. Safety of Urologic Surgical Interventions in the Elderly. Geriatric Nephrol. and Urol. 2: 105 (1992)

1. Franklin JR: Endoscopic treatment for papillary TCC of upper tract. National Medical Association. August 2-7, 1997
   
   
2. Franklin JR, Pang S, Dannul J. Sawyer C, Kaboo R, Tso C-L, and Belldegrun A: An Upstream regulatory region augments prostate specific antigen (PSA) promoter activity: In vivo studies. National Medical Association. August 2-7, 1997
   
   
3. Franklin JR, Dorey J, Patel A, Litwin MS, deKernion J: Improved continence after radical retropubic prostatectomy: A modified apical dissection. National Medical Association. August 2-7, 1997
   
   
4. Franklin J, Pang S, Dannul J, Sawyer C, Kaboo R, Tso C-L, and Belldegrun A: Cloning of an upstream regulatory region augments prostate specific antigen (PSA) promoter activity: In vivo studies. (Abstract) accepted AUA, April, 1997
   
   
5. Belldegrun A, Franklin J, Dorey F, Rauch J, deKernion J, and Figlin R: Immunotherapy for renal cell carcinoma: The UCLA experience. (Abstract) accepted AUA, April, 1997
   
   
6. Seltzer M, Hoh C, Franklin J, Naitoh J, Gitlitz B, Figlin R, Silverman D, deKernion J, Phelps M, Belldegrun A: Positron emission tomography (PET) imaging for staging of renal, testicular, and prostatic neoplasms. (Abstract) accepted AUA, April, 1997
   
   
7. Naitoh J, Franklin J, Patel A, and deKernion J: Comparing results of patient-based and physician-based reported rates of urinary incontinence following radical prostatectomy. (Abstract) accepted AUA, April, 1997
   
   
8. Hoh CK, Figlin RA, Seltzer MA, Belldegrun A, Franklin J, Gitlitz B, Phelps ME, Maddahi J: Prognostic value of a whole body FDG PET vs conventional imaging for the evaluation of biologic therapy in renal cell carcinoma. (Abstract) The Society of Nuclear Medicine 44th Annual Meeting, June, 1997
   
   
9. deKernion JB, Franklin J, and Patel A: Radical retropubic prostatectomy: Improved continence after a modified apical dissection. Western Section American Urological Association (72nd Annual Meeting). (Abs. 3) Jul 28 - Aug 1, 1996
   
   
10. Belldegrun A, Franklin J, Dorey F, Gitlitz B, Rauch J, deKernion J, Figlin R: Patients with metastatic cell carcinoma (mRCC) treated with IL-2 based immunotherapy with or without tumor infiltrating lymphocytes: Long term survival. Western Section American Urological Association (72nd Annual Meeting). (Abs. 109) Jul 28 - Aug 1, 1996
    
    
11. Franklin J, Dorey F, Gitlitz B, deKernion J, Figlin R, and Belldegrun A: The role of combination surgery and immunotherapy in the management of advanced renal cell carcinoma. Western Section American Urological Association (72nd Annual Meeting). (Abs. 110) Jul 28 - Aug 1, 1996
    
    
12. Franklin JR, deKernion JB, Patel A, Smith RB, Dorey F, and Rajfer J: Peyronie’s disease occurring after radical retropubic prostatectomy: Fact or friction. Western Section American Urological Association (72nd Annual Meeting). (Abs. 166) Jul 28 - Aug 1, 1996
    
    
13. Hoh CK, Figlin RA, Belldegrun A, Moon DH, Franklin J, Phelps ME, and Maddahi J: Evaluation of renal cell carcinoma with whole body FDG PET. Proceeding of the 43rd annual meeting of the society of nuclear medicine. J Nuclear Med., 37(suppl): 141P, 1996
    
    
14. Franklin J, Marks L, Dorey F, Shery ED, and deKernion J: Serum PSA levels following TURP in men with BPH: Long-term characterization. Proceeding of the American Urologic Association. J Urol., 155(suppl): 378A, 1996
    
    
15. Belldegrun A, Franklin J, Dorey F, Rauch J, deKernion J, and Figlin R: Long term survival of 181 patients with metastatic renal cell carcinoma (mRCC) treated with IL-2 based immunotherapy with/without tumor infiltrating lymphocytes. Proceeding of the American Urologic Association. J Urol., 155(suppl): 385A, 1996
    
    
16. Sokoloff M, Tso C-L, Franklin J, Nelson S, Dorey F, deKernion J, and Belldegrun A: Quantitative polymerase chain reaction [PCR] does not improve prostate cancer [PC] staging: A clinical-pathologic-molecular analysis of 121 patients. Proceeding of the American Urologic Association. J Urol., 155(suppl): 417A, 1996
    
    
17. Franklin J, Pang S, Sawyer C, Kaboo R, Tso C-L, deKernion J, and Belldegrun A: Prostate specific gene therapy using a novel PSA promoter: In vivo studies. Proceeding of the American Urologic Association. J Urol., 155(suppl): 437A, 1996
    
    
18. Dorey F, Franklin J, deKernion J, and Smith R: Use of multiple PSA values for predicting clinical disease recurrence after radical retropubic prostatectomy (RRP). Proceeding of the American Urologic Association. J Urol., 155(suppl): 487A, 1996
    
    
19. Franklin J, Dorey F, Gitlitz B, deKernion J, Figlin R, and Belldegrun A: Cytoreductive nephrectomy in 63 consecutive patients who received adoptive immunotherapy for advanced renal cell carcinoma. Proceeding of the American Urologic Association. J Urol., 155(suppl): 500A, 1996
    
    
20. Franklin J, Hoh C, Gitlitz B, Phelps M, Figlin R, and Belldegrun A: Positron emission tomography (PET) scan for imaging of advanced renal cell carcinoma (RCC). Proceeding of the American Urologic Association. J Urol., 155(suppl): 581A, 1996
    
    
21. Sokoloff M, Tso C-L, Randhir K, Franklin J, deKernion J, Pang S, Belldegrun A: Super-sensitive and quantitative polymerase chain reaction (PCR): An innovative technique for staging and monitoring prostate cancer. J Urol 153:294A, 1995
    
    
22. deKernion J, and Franklin J: Improved preservation of continence after radical prostatectomy or cystectomy. Pan African Urological Surgeons’ Association (2nd Biennial Conference) Sept 4-8, 1995
    
    
23. deKernion J, Raz S, Franklin J, and Seto E: Long-term results of the continent ileocecal urinary reservoir. Pan African Urological Surgeons’ Association (2nd Biennial Conference) Sept 4-8, 1995
    
    
24. Franklin JR, Raz S, and deKernion JB: Ileocolonic female neobladder. Western Section American Urological Association (71st Annual Meeting). (Abs. 168) Nov 5-9, 1995
    
    
25. deKernion JB, Trapasso JG, Franklin JR: Improved continence following radical retropubic prostatectomy: a modified apical dissection. Western Section American Urological Association (71st Annual Meeting). (Abs. 78) Nov 5-9, 1995
    
    
26. Franklin JR, and deKernion JB: Radiation therapy for localized recurrence after radical retropubic prostatectomy. Western Section American Urological Association (71st Annual Meeting). (Abs. 233) Nov 5-9, 1995
    
    
27. Sokoloff M, Tso C-L, Kaboo R, Franklin J, deKernion J, Pang S, Figlin R, and Belldegrun A: Improved prostate cancer (PC) staging using super-sensitive and quantitative polymerase chain reaction (PCR). Western Section American Urological Association (71st Annual Meeting). (Abs. 51) Nov 5-9, 1995
    
    
28. Barbara GJ, Franklin JR, Figlin, RA, William P, deKernion J, Belldegrun A: Tumor infiltrating lymphocyte (TIL) based therapy for metastatic renal cell carcinoma (RCC). The UCLA Kidney Cancer Program. National Medical Association (Centennial Meeting). July 30, 1995
    
    
29. Franklin, JR, and Hensle, T: Conservative management of renal pelvic lesions in children. Pan African Urological Surgeons Association (Inaugural international conference). Harare, Zimbabwe, May 1992
    
    
30. Franklin JR, Olsson CA, and Buttyan R. Homeobox gene expression in the mammalian prostate gland. Pan African Urological Surgeons Association (Inaugural international conference). Harare, Zimbabwe, May 1992
    
    
31. Franklin JR, Olsson CA, and Buttyan R. Expression of homeobox genes in the rat ventral prostate gland. J Urol 147: 318A (1992)
    
    
32. Franklin, J: The novel expression of homeobox genes in the mammalian prostate. Ferdinand C. Valentine Urology Residents’ Essay Meeting. (The New York Section of the AUA, Inc., April 1992) Abstract 74
    
    
33. Franklin JR, and Bittman R, Ph.D. Synthesis of the alkyl ether phospholipid, rac-glycerol-3-phosphorylcholine 1-dodecyl ether 2-eicosyl ether and 1-eicosyl ether 2-dodecyl ether. 17th marm Abstract Booklet (ACS, April 1983) p. 208

• Franklin JR, Dorey J, Patel A, Litwin MS, deKernion J: Improved continence after radical retropbic prostatectomy: A modified apical dissection

Franklin Freighting - July 1979 - March 1980

• Worked with father on Freighter

Road Primary School in Anguilla - April 1980 - July 1980

• Taught students in Primary School

Faith Tabernacle Baptist Church - June 1984 - August 1984

• Coordinated and taught in the summer educational program for junior and high school students in the Jamaica, New York area

Columbia University - June 1985 - August 1985

1. Taught MCAT preparation course summer of 1985
2. Taught College Preparation Course to pre-college students

• Scuba Diving (Certified Advanced Diver), Swimming, Traveling, and Reading